Equity Overview
Price & Market Data
Price: $0.186
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $2,098,359
Volume: 0
Performance Metrics
1 Week: 4.06%
1 Month: -19.72%
3 Months: -7.00%
6 Months: 17.80%
1 Year: 90.00%
YTD: -29.26%
Company Details
Employees: 4
Sector: Finance
Industry: Financial conglomerates
Country: United States
Details
QHSLab, Inc., a medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics. It develops digital healthcare, clinical decision support and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system QHSLab, cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. The company was incorporated in 1983 and is based in West Palm Beach, Florida.